How should we tackle antimalarial resistance in Africa before novel antimalarials become available?

In this presentation, Professor Karen I. Barnes (University of Cape Town; Director, WWARN Pharmacology; Founding Director, CCOAT; Coordinator, MARC SE-Africa) discusses strategies to address emerging antimalarial drug resistance across Africa. She highlights the urgent need for strengthened surveillance, stewardship of current therapies, improved coordination, and operational research to mitigate resistance threats while awaiting new antimalarial compounds. The session emphasizes co-creative approaches involving national malaria programs, technical working groups, and regional partnerships.